Skip to main content
Top
Published in: Cancer Causes & Control 10/2019

01-10-2019 | Kidney Cancer | Letter to the Editor

Low serum cholesterol as a risk factor for kidney and bladder cancer among Korean men: using a national cohort sample

Authors: Jisun Lim, Seo Young Kang, Hye Soon Park

Published in: Cancer Causes & Control | Issue 10/2019

Login to get access

Excerpt

The relationship between serum cholesterol level and cancer risk is controversial. Recent studies showed that low preoperative serum cholesterol levels may be associated with worse pathologic outcomes and poor cancer-specific survival in patients with renal cell carcinoma [1, 2]. However, it is unclear whether low serum cholesterol can increase the risk of urologic cancer incidence. We investigated the association between serum total cholesterol and the incidence of kidney and bladder cancer among Korean men using a national cohort sample. …
Literature
1.
go back to reference Ohno Y, Nakashima J, Nakagami Y (2014) Clinical implications of preoperative serum total cholesterol in patients with clear cell renal cell carcinoma. Urology 83(1):154–158CrossRefPubMed Ohno Y, Nakashima J, Nakagami Y (2014) Clinical implications of preoperative serum total cholesterol in patients with clear cell renal cell carcinoma. Urology 83(1):154–158CrossRefPubMed
2.
go back to reference de Martino M, Leitner CV, Seemann C (2015) Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC). BJU Int 115(3):397–404CrossRefPubMed de Martino M, Leitner CV, Seemann C (2015) Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC). BJU Int 115(3):397–404CrossRefPubMed
3.
go back to reference Lee J, Lee JS, Park SH (2017) Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol 46(2):e15PubMed Lee J, Lee JS, Park SH (2017) Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol 46(2):e15PubMed
4.
go back to reference Friedman GD, Flick ED, Udaltsova N (2008) Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf 17(1):27–36CrossRefPubMed Friedman GD, Flick ED, Udaltsova N (2008) Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf 17(1):27–36CrossRefPubMed
5.
go back to reference Payton S (2014) Kidney cancer: diabetes and low serum cholesterol are risk factors for RCC. Nat Rev Urol 11(8):422CrossRefPubMed Payton S (2014) Kidney cancer: diabetes and low serum cholesterol are risk factors for RCC. Nat Rev Urol 11(8):422CrossRefPubMed
Metadata
Title
Low serum cholesterol as a risk factor for kidney and bladder cancer among Korean men: using a national cohort sample
Authors
Jisun Lim
Seo Young Kang
Hye Soon Park
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 10/2019
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-019-01219-6

Other articles of this Issue 10/2019

Cancer Causes & Control 10/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine